Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania

被引:14
|
作者
Ngalesoni, Frida [1 ,2 ]
Ruhago, George [3 ]
Mayige, Mary [4 ]
Oliveira, Tiago Cravo [5 ]
Robberstad, Bjarne [6 ]
Norheim, Ole Frithjof [2 ]
Higashi, Hideki [7 ]
机构
[1] Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania
[2] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway
[3] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania
[4] Tanzania Natl Inst Med Res, Dar Es Salaam, Tanzania
[5] Inst Hlth Metr & Evaluat, Seattle, WA USA
[6] Univ Bergen, Ctr Int Hlth, Bergen, Norway
[7] Japan Int Cooperat Agcy, Lusaka, Zambia
来源
PLOS ONE | 2017年 / 12卷 / 08期
关键词
SMOKING-CESSATION; CIGARETTE-SMOKING; REDUCING SMOKING; HEALTH; IMPACT; PREVALENCE; INDICATORS; TRENDS; TAXES;
D O I
10.1371/journal.pone.0182113
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Tobacco consumption contributes significantly to the global burden of disease. The prevalence of smoking is estimated to be increasing in many low-income countries, including Tanzania, especially among women and youth. Even so, the implementation of tobacco control measures has been discouraging in the country. Efforts to foster investment in tobacco control are hindered by lack of evidence on what works and at what cost. Aims We aim to estimate the cost and cost-effectiveness of population-based tobacco control strategies in the prevention of cardiovascular diseases (CVD) in Tanzania. Materials and methods A cost-effectiveness analysis was performed using an Excel-based Markov model, from a governmental perspective. We employed an ingredient approach and step-down methodologies in the costing exercise following a government perspective. Epidemiological data and efficacy inputs were derived from the literature. We used disability-adjusted life years (DALYs) averted as the outcome measure. A probabilistic sensitivity analysis was carried out with Ersatz to incorporate uncertainties in the model parameters. Results Our model results showed that all five tobacco control strategies were very cost-effective since they fell below the ceiling ratio of one GDP per capita suggested by the WHO. Increase in tobacco taxes was the most cost-effective strategy, while a workplace smoking ban was the least cost-effective option, with a cost-effectiveness ratio of US$5 and US$267, respectively. Conclusions Even though all five interventions are deemed very cost-effective in the prevention of CVD in Tanzania, more research on budget impact analysis is required to further assess the government's ability to implement these interventions.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Cost-Effectiveness of Population-Based Tobacco Control Interventions on the Health Burden of Cardiovascular Diseases in Vietnam
    Duyen Thuy Nguyen
    Khue Ngoc Luong
    Hai Thi Phan
    Anh Tuan Tran
    Son The Dao
    Poudel, Ak Narayan
    Thang Manh Hoang
    Vuong Van Do
    Dat Minh Le
    Giang Huong Pham
    Linh Thuy Nguyen
    Anh Tu Duong
    Minh Van Hoang
    ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2021, 33 (08) : 854 - 860
  • [2] Cost-Effectiveness Analysis of Tobacco Control Strategies in Indonesia
    Matheos, Clark C.
    Liew, Danny
    Zomer, Ella
    Ademi, Zanfina
    VALUE IN HEALTH REGIONAL ISSUES, 2023, 33 : 65 - 75
  • [3] Framework for the Cost-Effectiveness of Secondary Prevention Strategies in Cardiovascular Diseases: A Canadian Theoretical Model-Based Analysis
    Fanton-Aita, Fiorella
    Matteau, Alexis
    Mitchell, Dominic
    Potter, Brian J.
    Iliza, Ange Christelle
    Guertin, Jason R.
    Dubois, Anick
    Dube, Marie-Pierre
    Tardif, Jean-Claude
    LeLorier, Jacques
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 353 - 353
  • [4] COST-EFFECTIVENESS OF TOBACCO CONTROL STRATEGIES IN INDONESIA
    Matheos, C. C.
    Liew, D.
    Zomer, E.
    Ademi, Z.
    VALUE IN HEALTH, 2022, 25 (01) : S93 - S93
  • [5] Cost-effectiveness of primary and secondary prevention in cardiovascular diseases
    Troche, CJ
    Tacke, J
    Hinzpeter, B
    Danner, M
    Lauterbach, KW
    EUROPEAN HEART JOURNAL, 1998, 19 : C59 - C65
  • [6] Model-based cost-effectiveness analysis of atorvastatin drugs for prevention of cardiovascular diseases in Iran
    Jabbari, Alireza
    Jafari, Abdosaleh
    Hadian, Marziye
    Ghasemi, Mohammad
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2020, 11 (01)
  • [7] Maximising the effectiveness and cost-effectiveness of cardiovascular disease prevention in the general population
    Tonkin, Andrew M.
    Boyden, Andrew N.
    Colagiuri, Stephen
    MEDICAL JOURNAL OF AUSTRALIA, 2009, 191 (06) : 300 - 302
  • [8] Prevention of cardiovascular diseases in Nairobi slums: a cost-effectiveness study
    van de Vijver, Steven
    Oti, Samuel
    Gomez, Gabriela B.
    Agyemang, Charles
    Lange, Joep
    Kyobutungi, Catherine
    LANCET, 2014, 384 : S12 - S12
  • [9] SECONDARY PREVENTION CARDIOVASCULAR PATIENTS IN IRELAND - POPULATION CHARACTERISTICS FOR COST-EFFECTIVENESS ANALYSIS
    O'Donnell, H.
    McCullagh, L.
    Barry, M.
    VALUE IN HEALTH, 2017, 20 (09) : A602 - A602
  • [10] Cost-Effectiveness of a Polypill for Cardiovascular Disease Prevention in an Underserved Population
    Kohli-Lynch, Ciaran N.
    Moran, Andrew E.
    Kazi, Dhruv S.
    Bibbins-Domingo, Kirsten
    Jordan, Neil
    French, Dustin
    Zhang, Yiyi
    Wang, Thomas J.
    Bellows, Brandon K.
    JAMA CARDIOLOGY, 2025, 10 (03) : 224 - 233